{"id":391892,"date":"2026-01-05T13:19:40","date_gmt":"2026-01-05T16:19:40","guid":{"rendered":"https:\/\/hcxfmusp.org.br\/portal\/?p=391892"},"modified":"2026-01-05T13:34:29","modified_gmt":"2026-01-05T16:34:29","slug":"cancer-ginecologico-ultimas-diretrizes","status":"publish","type":"post","link":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/","title":{"rendered":"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"391892\" class=\"elementor elementor-391892\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6083019 e-flex e-con-boxed e-con e-parent\" data-id=\"6083019\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-272998b7 elementor-widget elementor-widget-text-editor\" data-id=\"272998b7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;font-family: gabarito\"> <img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-391908 size-full\" src=\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico_diretrizes.png\" alt=\"c\u00e2ncer_ginecol\u00f3gico_diretrizes\" width=\"1300\" height=\"400\" srcset=\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico_diretrizes.png 1300w, https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico_diretrizes-300x92.png 300w, https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico_diretrizes-1024x315.png 1024w, https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico_diretrizes-768x236.png 768w\" sizes=\"(max-width: 1300px) 100vw, 1300px\" \/><\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">\u00a0<\/span><span style=\"font-weight: 400;font-family: gabarito\">A oncoginecologia brasileira enfrenta um cen\u00e1rio complexo: os protocolos s\u00e3o claros, mas a incid\u00eancia de tumores mant\u00e9m altos \u00edndices. Para o m\u00e9dico, independente do n\u00edvel de aten\u00e7\u00e3o, a atualiza\u00e7\u00e3o constante n\u00e3o \u00e9 apenas um diferencial de carreira, mas uma medida de seguran\u00e7a.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">\u201cA pior situa\u00e7\u00e3o para uma mulher \u00e9 descobrir, ap\u00f3s o diagn\u00f3stico, que existiam medidas simples e importantes de preven\u00e7\u00e3o que poderiam ter sido feitas e n\u00e3o foram\u201d, avalia o professor da Faculdade de Medicina da Universidade de S\u00e3o Paulo, Dr. Jesus Paula Carvalho.<\/span><\/p><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Dica: ao buscar conhecimento em oncoginecologia, busque <\/span><a href=\"https:\/\/ensino.hcxfmusp.org.br\/online\/cancer-gineco\/p\"><span style=\"font-weight: 400\">cursos de c\u00e2nceres ginecol\u00f3gicos<\/span><\/a><span style=\"font-weight: 400\"> que s\u00e3o oferecidos por hospitais de refer\u00eancia.\u00a0<\/span><\/span><\/p><h2>\u00a0<\/h2><h2><span style=\"font-family: gabarito;color: #005f61\"><b>C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil<\/b><\/span><\/h2><p><span style=\"font-weight: 400;font-family: gabarito\">Dominar as diretrizes mais recentes sobre c\u00e2nceres ginecol\u00f3gicos \u00e9 uma responsabilidade de todo m\u00e9dico, para garantir estrat\u00e9gias integradas de preven\u00e7\u00e3o, diagn\u00f3stico e tratamento multidisciplinares.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">Confira a seguir um guia com os principais dados e condutas &#8211; com dica especial ao final.<\/span><\/p><h2>\u00a0<\/h2><h2><span style=\"font-family: gabarito;color: #005f61\"><b>Tipos de c\u00e2ncer ginecol\u00f3gico mais incidentes no Brasil<\/b><\/span><\/h2><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Estimativas indicam que <\/span><a href=\"https:\/\/www.sboc.org.br\/noticias\/item\/3001-setembro-em-flor-mais-de-30-mil-brasileiras-sao-diagnosticadas-com-canceres-ginecologicos-a-cada-ano\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400\">mais de 30 mil brasileiras s\u00e3o diagnosticadas com c\u00e2nceres ginecol\u00f3gicos a cada ano. <\/span><\/a><span style=\"font-weight: 400\">\u00a0Segundo as <\/span><a href=\"https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/media\/document\/estimativa-2023.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400\">estimativas do INCA 2023\u20132025<\/span><\/a><span style=\"font-weight: 400\">, entre os 10 tumores mais incidentes em mulheres, tr\u00eas s\u00e3o ginecol\u00f3gicos.<\/span><\/span><\/p><table><tbody><tr><td><span style=\"font-weight: 400;font-family: gabarito\">Tipo de C\u00e2ncer<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">Casos Novos\/Ano<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">Percentual (%)<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">Posi\u00e7\u00e3o no Ranking Geral (Feminino)*<\/span><\/td><\/tr><tr><td><span style=\"font-weight: 400;font-family: gabarito\">Colo do \u00fatero<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">17.010<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">7,0%<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">3\u00aa<\/span><\/td><\/tr><tr><td><span style=\"font-weight: 400;font-family: gabarito\">Corpo do \u00fatero (endom\u00e9trio)<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">7.840<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">3,2%<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">7\u00aa<\/span><\/td><\/tr><tr><td><span style=\"font-weight: 400;font-family: gabarito\">Ov\u00e1rio<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">7.310<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">3,0%<\/span><\/td><td><span style=\"font-weight: 400;font-family: gabarito\">8\u00aa<\/span><\/td><\/tr><\/tbody><\/table><p>\u00a0<\/p><p><span style=\"font-weight: 400;font-family: gabarito\">H\u00e1 ainda o c\u00e2ncer de vulva, que apresenta menor incid\u00eancia, mas demanda aten\u00e7\u00e3o cl\u00ednica. \u201cSomados, esses c\u00e2nceres correspondem a pelo menos um ter\u00e7o de todos os tumores que acometem mulheres\u201d, revela o especialista.\u00a0<\/span><\/p><h2>\u00a0<\/h2><h2><span style=\"font-family: gabarito;color: #005f61\"><b>As principais diretrizes da oncoginecologia brasileira<\/b><\/span><\/h2><h3>\u00a0<\/h3><h3><span style=\"font-family: gabarito;color: #005f61\"><b>C\u00e2ncer do colo do \u00fatero<\/b><\/span><\/h3><p><span style=\"font-weight: 400;font-family: gabarito\">Relacionado \u00e0 infec\u00e7\u00e3o pelo HPV. Geralmente assintom\u00e1tico por anos, refor\u00e7ando a import\u00e2ncia do rastreamento e vacinas.<\/span><\/p><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Para que o <\/span><b>c\u00e2ncer do colo do \u00fatero<\/b><span style=\"font-weight: 400\"> deixe de ser o 3\u00ba mais frequente, o protocolo indicado pela Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS), foca nesses pilares:<\/span><\/span><\/p><ul><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><a href=\"https:\/\/bvsms.saude.gov.br\/vacina-contra-o-hpv-a-melhor-e-mais-eficaz-forma-de-protecao-contra-o-cancer-de-colo-de-utero\/\" target=\"_blank\" rel=\"noopener\"><b>Vacina\u00e7\u00e3o contra o HPV<\/b><\/a> <b>(preven\u00e7\u00e3o prim\u00e1ria).<\/b><\/span><\/li><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><b>Rastreamento (secund\u00e1ria):<\/b><span style=\"font-weight: 400\"> indicado para mulheres de 25 a 64 anos que j\u00e1 iniciaram a vida sexual &#8211; exame de Papanicolaou ou o teste de HPV (que identifica a presen\u00e7a do v\u00edrus antes da les\u00e3o existir).\u00a0<\/span><\/span><\/li><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><b>Tratamento de les\u00f5es n\u00e3o invasivas<\/b><span style=\"font-weight: 400\">: interven\u00e7\u00e3o em les\u00f5es n\u00e3o invasivas para evitar a progress\u00e3o da doen\u00e7a.<\/span><\/span><\/li><\/ul><h3><span style=\"font-family: gabarito\"><b>\u00a0<\/b><\/span><\/h3><h3><span style=\"font-family: gabarito;color: #005f61\"><b>C\u00e2ncer corpo do \u00fatero (endom\u00e9trio)<\/b><\/span><\/h3><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Acomete principalmente mulheres na p\u00f3s-menopausa. O principal sinal de alerta \u00e9 o <\/span><b>sangramento uterino ap\u00f3s a menopausa<\/b><span style=\"font-weight: 400\">.<\/span><\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">\u201cEntre os fatores de risco est\u00e3o a obesidade e o diabetes; somados \u00e0 baixa paridade (menos filhos por mulher) e ao aumento da expectativa de vida. Criamos um cen\u00e1rio onde o risco para esse tumor aumenta significativamente\u201d, explica o professor.\u00a0<\/span><\/p><h3><span style=\"font-family: gabarito\"><b>\u00a0<\/b><\/span><\/h3><h3><span style=\"font-family: gabarito;color: #005f61\"><b>C\u00e2ncer de ov\u00e1rio<\/b><\/span><\/h3><p><span style=\"font-weight: 400;font-family: gabarito\">O c\u00e2ncer de ov\u00e1rio, apesar de ser menos frequente, \u00e9 o mais agressivo. \u201cMetade das mulheres com c\u00e2ncer de ov\u00e1rio v\u00e3o a \u00f3bito nos primeiros 4 ou 5 anos\u201d, alerta Dr. Jesus.<\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">Por ter forte influ\u00eancia gen\u00e9tica, mulheres com hist\u00f3rico familiar devem realizar teste gen\u00e9tico para detectar muta\u00e7\u00f5es (como nos genes BRCA1 e BRCA2); se confirmadas, \u00e9 recomendado cirurgias profil\u00e1ticas (preventivas). \u201cAp\u00f3s a fase reprodutiva, a recomenda\u00e7\u00e3o \u00e9 retirar os ov\u00e1rios\u201d, completa.\u00a0<\/span><\/p><h2><span style=\"font-family: gabarito\"><b>\u00a0<\/b><\/span><\/h2><h2><span style=\"font-family: gabarito;color: #005f61\"><b>Avan\u00e7os no diagn\u00f3stico precoce do c\u00e2ncer ginecol\u00f3gico e erros comuns<\/b><\/span><\/h2><p><span style=\"font-weight: 400;font-family: gabarito\">O diagn\u00f3stico precoce \u00e9 um dos principais fatores que influenciam o progn\u00f3stico do c\u00e2ncer ginecol\u00f3gico. Ou seja, reconhecer a doen\u00e7a em sua fase inicial aumenta as chances de cura e tratamentos menos invasivos.<\/span><\/p><h4><span style=\"font-weight: 400;font-family: gabarito\">Entre os avan\u00e7os mais relevantes est\u00e3o:<\/span><\/h4><ul><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Substitui\u00e7\u00e3o gradual do <\/span><b>Papanicolau pelo teste de HPV<\/b><span style=\"font-weight: 400\"> como estrat\u00e9gia de rastreamento do c\u00e2ncer do colo do \u00fatero. \u201cSe n\u00e3o houver HPV de alto risco, sabemos por estudos pr\u00e9vios que a paciente n\u00e3o vai desenvolver c\u00e2ncer invasivo nos pr\u00f3ximos cinco anos. Ainda, o teste de HPV pode ser automatizado e realizado por m\u00e1quinas\u201d, esclarece o profissional;<\/span><\/span><\/li><\/ul><ul><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Evolu\u00e7\u00e3o dos <\/span><b>exames de imagem<\/b><span style=\"font-weight: 400\"> (ultrassonografia, tomografia, resson\u00e2ncia magn\u00e9tica e PET-CT);<\/span>\u00a0<\/span><\/li><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Expans\u00e3o da <\/span><b>radiologia intervencionista<\/b><span style=\"font-weight: 400\">, permitindo bi\u00f3psias menos invasivas;<\/span>\u00a0<\/span><\/li><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><b>Cirurgias mais precisas.<\/b><span style=\"font-weight: 400\"> \u201cA tend\u00eancia s\u00e3o procedimentos cada vez mais precisos e menos invasivos\u201d.<\/span>\u00a0<\/span><\/li><\/ul><p><span style=\"font-weight: 400;font-family: gabarito\">\u00a0<\/span><\/p><h4><span style=\"font-weight: 400;font-family: gabarito\">Entre os erros mais comuns est\u00e3o:<\/span><\/h4><ul><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Confundir sangramento patol\u00f3gico com menstrua\u00e7\u00e3o e deixar de investigar sangramento na p\u00f3s-menopausa;<\/span>\u00a0<\/span><\/li><li style=\"font-weight: 400\"><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Uso inadequado de <\/span><b>marcadores tumorais<\/b><span style=\"font-weight: 400\"> como m\u00e9todo de rastreamento. H\u00e1 m\u00e9dicos que podem utilizar marcadores tumorais inadequadamente e gerar falsos positivos em condi\u00e7\u00f5es benignas como peritonite ou endocardite, criando ansiedade desnecess\u00e1ria;<\/span><\/span><\/li><li style=\"font-weight: 400\"><span style=\"font-weight: 400;font-family: gabarito\">Falta de investiga\u00e7\u00e3o do hist\u00f3rico familiar para c\u00e2ncer heredit\u00e1rio.<\/span><\/li><\/ul><h2>\u00a0<\/h2><h2><span style=\"font-family: gabarito;color: #005f61\"><b>Tratamento do c\u00e2ncer ginecol\u00f3gico: quando indicar cirurgia, quimioterapia ou radioterapia?<\/b><\/span><\/h2><p><span style=\"font-weight: 400;font-family: gabarito\">Na oncoginecologia, tratar o c\u00e2ncer exige ir al\u00e9m de protocolos gen\u00e9ricos. Com a vida do paciente em risco, o tratamento personalizado \u00e9 sempre a melhor op\u00e7\u00e3o.\u00a0<\/span><\/p><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">A recomenda\u00e7\u00e3o do especialista \u00e9 manter um <\/span><span style=\"font-weight: 400\">\u201ctumor board\u201d &#8211; uma reuni\u00e3o em que os especialistas (como cirurgi\u00e3o, r\u00e1dio-oncologista, imunologista, etc.) discutem qual a combina\u00e7\u00e3o de tratamento para os melhores resultados.<\/span><\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">\u201cExistem estudos mostrando que pacientes abordados desta forma t\u00eam um diagn\u00f3stico e um tratamento at\u00e9 30% melhor do que aqueles tratados por um \u00fanico especialista\u201d, destaca o professor.\u00a0<\/span><\/p><h2>\u00a0<\/h2><h2><span style=\"font-family: gabarito;color: #005f61\"><b>Forma\u00e7\u00e3o em c\u00e2ncer ginecol\u00f3gico: sua pr\u00f3xima etapa<\/b><\/span><\/h2><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Um <\/span><a href=\"https:\/\/ensino.hcxfmusp.org.br\/online\/cancer-gineco\/p\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400\">curso atualizado de c\u00e2ncer ginecol\u00f3gico<\/span><\/a><span style=\"font-weight: 400\"> prepara voc\u00ea para atuar com seguran\u00e7a cl\u00ednica e ser reconhecido pelo mercado.\u00a0<\/span><\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">Aproveite a oportunidade de aprender sobre c\u00e2nceres ginecol\u00f3gicos com especialista do Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP) &#8211; refer\u00eancia mundial na \u00e1rea.<\/span><\/p><p><span style=\"font-weight: 400;font-family: gabarito\">A forma\u00e7\u00e3o \u00e9 recomendada para todos os perfis m\u00e9dicos &#8211; aqueles que precisam do conhecimento b\u00e1sico para diagnosticar e evitar erros; at\u00e9 profissionais que atuam em pacientes de m\u00e9dia ou alta complexidade.\u00a0<\/span><\/p><p><span style=\"font-family: gabarito\"><span style=\"font-weight: 400\">Acesse a p\u00e1gina do <\/span><a href=\"https:\/\/ensino.hcxfmusp.org.br\/online\/cancer-gineco\/p\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400\">curso de c\u00e2ncer ginecol\u00f3gico<\/span><\/a><span style=\"font-weight: 400\"> e saiba mais!\u00a0<\/span><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>\u00a0A oncoginecologia brasileira enfrenta um cen\u00e1rio complexo: os protocolos s\u00e3o claros, mas a incid\u00eancia de tumores mant\u00e9m altos \u00edndices. Para o m\u00e9dico, independente do n\u00edvel de aten\u00e7\u00e3o, a atualiza\u00e7\u00e3o constante n\u00e3o \u00e9 apenas um diferencial de carreira, mas uma medida de seguran\u00e7a.\u00a0 \u201cA pior situa\u00e7\u00e3o para uma mulher \u00e9 descobrir, ap\u00f3s o diagn\u00f3stico, que existiam [&hellip;]<\/p>\n","protected":false},"author":4302,"featured_media":391894,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[390],"tags":[1182,1181,1183,1184,1178,1180,1179,1186,1023,1185],"class_list":["post-391892","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-cancer-corpo-do-endometrio","tag-cancer-corpo-do-utero","tag-cancer-de-ovario","tag-cancer-do-colo-do-utero","tag-cancer-ginecologico","tag-curso-de-cancer-ginecologico","tag-oncoginecologia-brasileira","tag-quimioterapia","tag-radioterapia","tag-tratamento-do-cancer-ginecologico"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.5 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes - HCX - Portal<\/title>\n<meta name=\"description\" content=\"C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil. Atualiza-se e seja reconhecido por todos!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes\" \/>\n<meta property=\"og:description\" content=\"C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil. Atualiza-se e seja reconhecido por todos!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\" \/>\n<meta property=\"og:site_name\" content=\"HCX - Portal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/hcxfmusp\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-05T16:19:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-05T16:34:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"337\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Lilian\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lilian\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\"},\"author\":{\"name\":\"Lilian\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/person\/e1fe7cac210d7f80fd3553671836a4a5\"},\"headline\":\"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes\",\"datePublished\":\"2026-01-05T16:19:40+00:00\",\"dateModified\":\"2026-01-05T16:34:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\"},\"wordCount\":1032,\"publisher\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#organization\"},\"image\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png\",\"keywords\":[\"C\u00e2ncer corpo do endom\u00e9trio\",\"C\u00e2ncer corpo do \u00fatero\",\"C\u00e2ncer de ov\u00e1rio\",\"C\u00e2ncer do colo do \u00fatero\",\"C\u00e2ncer ginecol\u00f3gico\",\"curso de c\u00e2ncer ginecol\u00f3gico\",\"oncoginecologia brasileira\",\"quimioterapia\",\"Radioterapia\",\"Tratamento do c\u00e2ncer ginecol\u00f3gico\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\",\"url\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\",\"name\":\"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes - HCX - Portal\",\"isPartOf\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png\",\"datePublished\":\"2026-01-05T16:19:40+00:00\",\"dateModified\":\"2026-01-05T16:34:29+00:00\",\"description\":\"C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil. Atualiza-se e seja reconhecido por todos!\",\"breadcrumb\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage\",\"url\":\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png\",\"contentUrl\":\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png\",\"width\":600,\"height\":337,\"caption\":\"c\u00e2ncer ginecol\u00f3gico\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/hcxfmusp.org.br\/portal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#website\",\"url\":\"https:\/\/hcxfmusp.org.br\/portal\/\",\"name\":\"Portal\",\"description\":\"Portal - HCX Fmusp\",\"publisher\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hcxfmusp.org.br\/portal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#organization\",\"name\":\"HCX Fmusp\",\"url\":\"https:\/\/hcxfmusp.org.br\/portal\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2024\/03\/logo-hcx-fmusp.png\",\"contentUrl\":\"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2024\/03\/logo-hcx-fmusp.png\",\"width\":879,\"height\":384,\"caption\":\"HCX Fmusp\"},\"image\":{\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/hcxfmusp\",\"https:\/\/www.instagram.com\/hcxfmusp\",\"https:\/\/www.linkedin.com\/company\/hcxfmusp\",\"https:\/\/www.youtube.com\/@hcxfmusp\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/person\/e1fe7cac210d7f80fd3553671836a4a5\",\"name\":\"Lilian\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/22c4f0aa119eefc74222f54eb3bd8ad5c5762a26510bfcd9c091c72b146b3763?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/22c4f0aa119eefc74222f54eb3bd8ad5c5762a26510bfcd9c091c72b146b3763?s=96&d=mm&r=g\",\"caption\":\"Lilian\"},\"url\":\"https:\/\/hcxfmusp.org.br\/portal\/author\/lilian\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes - HCX - Portal","description":"C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil. Atualiza-se e seja reconhecido por todos!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/","og_locale":"pt_BR","og_type":"article","og_title":"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes","og_description":"C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil. Atualiza-se e seja reconhecido por todos!","og_url":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/","og_site_name":"HCX - Portal","article_publisher":"https:\/\/www.facebook.com\/hcxfmusp","article_published_time":"2026-01-05T16:19:40+00:00","article_modified_time":"2026-01-05T16:34:29+00:00","og_image":[{"width":600,"height":337,"url":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png","type":"image\/png"}],"author":"Lilian","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Lilian","Est. tempo de leitura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#article","isPartOf":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/"},"author":{"name":"Lilian","@id":"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/person\/e1fe7cac210d7f80fd3553671836a4a5"},"headline":"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes","datePublished":"2026-01-05T16:19:40+00:00","dateModified":"2026-01-05T16:34:29+00:00","mainEntityOfPage":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/"},"wordCount":1032,"publisher":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage"},"thumbnailUrl":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png","keywords":["C\u00e2ncer corpo do endom\u00e9trio","C\u00e2ncer corpo do \u00fatero","C\u00e2ncer de ov\u00e1rio","C\u00e2ncer do colo do \u00fatero","C\u00e2ncer ginecol\u00f3gico","curso de c\u00e2ncer ginecol\u00f3gico","oncoginecologia brasileira","quimioterapia","Radioterapia","Tratamento do c\u00e2ncer ginecol\u00f3gico"],"articleSection":["Blog"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/","url":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/","name":"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes - HCX - Portal","isPartOf":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage"},"image":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage"},"thumbnailUrl":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png","datePublished":"2026-01-05T16:19:40+00:00","dateModified":"2026-01-05T16:34:29+00:00","description":"C\u00e2ncer ginecol\u00f3gico: classifica\u00e7\u00e3o, incid\u00eancia e desafios atuais no Brasil. Atualiza-se e seja reconhecido por todos!","breadcrumb":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#primaryimage","url":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png","contentUrl":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2026\/01\/cancer_ginecologico.png","width":600,"height":337,"caption":"c\u00e2ncer ginecol\u00f3gico"},{"@type":"BreadcrumbList","@id":"https:\/\/hcxfmusp.org.br\/portal\/cancer-ginecologico-ultimas-diretrizes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/hcxfmusp.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Guia de c\u00e2ncer ginecol\u00f3gico para m\u00e9dicos: \u00faltimas diretrizes"}]},{"@type":"WebSite","@id":"https:\/\/hcxfmusp.org.br\/portal\/#website","url":"https:\/\/hcxfmusp.org.br\/portal\/","name":"Portal","description":"Portal - HCX Fmusp","publisher":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hcxfmusp.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/hcxfmusp.org.br\/portal\/#organization","name":"HCX Fmusp","url":"https:\/\/hcxfmusp.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2024\/03\/logo-hcx-fmusp.png","contentUrl":"https:\/\/hcxfmusp.org.br\/portal\/wp-content\/uploads\/2024\/03\/logo-hcx-fmusp.png","width":879,"height":384,"caption":"HCX Fmusp"},"image":{"@id":"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/hcxfmusp","https:\/\/www.instagram.com\/hcxfmusp","https:\/\/www.linkedin.com\/company\/hcxfmusp","https:\/\/www.youtube.com\/@hcxfmusp"]},{"@type":"Person","@id":"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/person\/e1fe7cac210d7f80fd3553671836a4a5","name":"Lilian","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/hcxfmusp.org.br\/portal\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/22c4f0aa119eefc74222f54eb3bd8ad5c5762a26510bfcd9c091c72b146b3763?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22c4f0aa119eefc74222f54eb3bd8ad5c5762a26510bfcd9c091c72b146b3763?s=96&d=mm&r=g","caption":"Lilian"},"url":"https:\/\/hcxfmusp.org.br\/portal\/author\/lilian\/"}]}},"_links":{"self":[{"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/posts\/391892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/users\/4302"}],"replies":[{"embeddable":true,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/comments?post=391892"}],"version-history":[{"count":17,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/posts\/391892\/revisions"}],"predecessor-version":[{"id":391914,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/posts\/391892\/revisions\/391914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/media\/391894"}],"wp:attachment":[{"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/media?parent=391892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/categories?post=391892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hcxfmusp.org.br\/portal\/wp-json\/wp\/v2\/tags?post=391892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}